Collection of skin biopsy with hair follicles as surrogate to develop biomarker assays from patients with advanced solid tumor malignancies receiving either single agent weekly irinotecan or gemcitabine.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Gemcitabine; Irinotecan
- Indications Solid tumours
- Focus Biomarker; Pharmacodynamics
- 08 Apr 2013 Biomarkers information updated
- 28 Aug 2007 Status changed from recruiting to completed.
- 21 Oct 2006 New trial record.